Vaccinex (VCNX) Earnings Date, Estimates & Call Transcripts → Nvidia’s Quiet $1 Trillion Pivot (From Weiss Ratings) (Ad) Free VCNX Stock Alerts $7.00 +0.59 (+9.20%) (As of 10:33 AM ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 12EstimatedActual EPS (Apr. 2) -$39.40 Missed By -$39.40 Get Vaccinex Earnings AlertsEnter your email address below to receive the latest news and earnings results for VCNX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVCNX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VCNX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. VCNX Earnings Date and InformationVaccinex last announced its earnings results on April 2nd, 2024. The reported ($39.40) earnings per share for the quarter. Vaccinex has generated ($82.80) earnings per share over the last year (($82.80) diluted earnings per share). Vaccinex has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.Read More Vaccinex Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/12/2024(Estimated)------- 4/2/2024Q4 2023-($39.40)($39.40)($39.40)--11/13/2023Q3 2023-($15.26)($15.26)($1.09)-$0.02 million8/14/2023Q2 2023-($25.20)($25.20)($0.12)--5/15/2023Q1 2023-($21.00)($21.00)($0.10)-$0.55 million4/3/2023Q4 2022-($23.10)($23.10)($0.11)-$0.23 million11/14/2022Q3 2022-($23.10)($23.10)($0.11)-$0.05 million Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 8/15/2022Q2 2022-($27.30)($27.30)($0.13)--5/16/2022Q1 2022-($25.20)($25.20)($0.12)--3/31/2022Q4 2021-($31.50)($31.50)($0.15)--11/8/2021Q3 2021($60.90)($35.70)+$25.20($0.17)-$0.05 million8/16/2021Q2($60.90)($44.10)+$16.80($0.21)--5/17/2021Q1 2021($73.50)($54.60)+$18.90($0.26)-$0.85 million11/13/2020Q3($111.30)($92.40)+$18.90($0.44)-$0.05 million8/14/2020Q2 2020($107.10)($81.90)+$25.20($0.39)--5/14/2020Q1 2020($157.50)($93.8246)+$63.6754($0.45)$0.10 million-3/9/2020Q4 2019($121.80)($79.80)+$42.00($0.38)--11/12/2019Q3($138.60)($117.60)+$21.00($0.56)-$0.40 million8/14/2019Q2 2019($147.00)($161.4978)($14.4978)($0.77)-$0.03 million Vaccinex Earnings - Frequently Asked Questions When is Vaccinex's earnings date? Vaccinex has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on VCNX's earnings history. How much revenue does Vaccinex generate each year? Vaccinex (NASDAQ:VCNX) has a recorded annual revenue of $570,000.00. How much profit does Vaccinex generate each year? Vaccinex (NASDAQ:VCNX) has a recorded net income of -$20.25 million. VCNX has generated -$82.80 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Unicycive Therapeutics Earnings Results RenovoRx Earnings Results ProMIS Neurosciences Earnings Results Viracta Therapeutics Earnings Results Bolt Biotherapeutics Earnings Results ImmunoPrecise Antibodies Earnings Results JanOne Earnings Results Spruce Biosciences Earnings Results Oncternal Therapeutics Earnings Results BioVie Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:VCNX) was last updated on 6/6/2024 by MarketBeat.com Staff From Our PartnersBitcoin’s Biggest Year Yet2024 is set to be a historic year for Bitcoin. It’s all thanks to three major catalysts that I reveal in my...Paradigm Press | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredTrump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absoluteDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredEverything from semiconductors to space shuttles depend on this overlooked mineralBoron is also at the heart of a breakthrough that could fuel one of mankind's most sensational advances in sem...Capital Trends | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored[Webinar] Understanding Covered CallsDiscover the details of this option-selling strategy.OIC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.